This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Mike Morrison - Innovator in Cell and Organ Survivability
Introduction
Mike Morrison is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biological sciences, particularly in enhancing the survivability of cells, tissues, and organs. His innovative work has implications for various therapeutic applications, including organ transplantation and cancer treatment.
Latest Patents
Morrison holds a patent titled "Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms." This invention focuses on the use of oxygen antagonists and other active compounds to induce stasis or pre-stasis in biological materials. The patent encompasses compositions, methods, articles of manufacture, and apparatuses aimed at preserving and protecting cells, tissues, and organs. Specific applications of this invention include therapeutic methods for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer.
Career Highlights
Mike Morrison is affiliated with the Fred Hutchinson Cancer Center, where he continues to advance research in the field of cell and organ survivability. His work is crucial in developing new therapeutic strategies that can significantly improve patient outcomes.
Collaborations
Morrison collaborates with esteemed colleagues, including Mark B Roth and Eric Blackstone, who contribute to the research and development of innovative solutions in the medical field.
Conclusion
Mike Morrison's contributions to the field of biological sciences through his patent and work at the Fred Hutchinson Cancer Center highlight his commitment to enhancing the survivability of vital biological materials. His innovative approaches have the potential to transform therapeutic practices and improve health outcomes for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
